Cardiovascular Therapeutic Drugs: Technologies and Global Markets

August 09, 2010

Wellesley, Mass. – According to a new technical market research report, CARDIOVASCULAR THERAPEUTIC DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (PHM024B) from BCC Research (www.bccresearch.com), the global market for cardiovascular therapeutic drugs is estimated to be worth $144 billion in 2010, but is expected to decrease to less than $140 billion in 2015, for a compound annual growth rate (CAGR) of -0.7%.

The largest segment of the market, made up of hypertension drugs, is expected to decrease at a 5-year CAGR of -3.9%, falling from an estimated $65.3 billion in 2010 to less than $54 billion in 2015.

The segment made up of hyperlipidemia drugs is expected to drop from nearly $32.4 billion in 2010 to about $26 billion in 2015, for a CAGR of -4.3%.

The segment made up of thrombosis drugs will have positive growth. It is expected to rise from $26.3 billion in 2010 to $29.3 billion in 2015, for a CAGR of 2.2%.

The segment with the largest CAGR at 11%, cardiac failure therapy, is projected to increase to $16 billion in 2015 from $9.5 billion in 2010.

This study provides a comprehensive analysis of cardiovascular therapies on a global basis. Its aim is to provide a range of information, from detailed product analyses within disease subsegments to overall industry trends, in order to quantify and qualify the market for therapeutic drug products in the segment.

The cardiovascular therapeutic market is the largest of any drug sector. In addition, companies that hold patent rights to the largest drug classes have elected to exit the sector, opening the market up to the next tier of participants.

The report includes analysis of leading and emerging competitors in the current worldwide cardiovascular market. Profiles of manufacturers of leading products as well as biotechnology companies with novel products in development are analyzed to define their specific product strategies employed.

This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the cardiovascular market, its products, its industry participants and its future.

Cardiovascular Therapeutic Drugs: Technologies and Global Markets( PHM024B )
Publish Date: Jul 2010    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.